Frank Steven — SEC insider filings

SEC reporting owner CIK 1583886. 22 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 22 filings on record, filed 2021-03-05 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PRECIGEN, INC. (PGEN)Director131 leg · 400,000 sh · $688,000—32
BIOCRYST PHARMACEUTICALS INC (BCRX)Director9——12

Insider filings — Frank Steven

FiledFormIssuerReported transactionsSource
2026-09-024BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 1,288 @ $9.70EDGAR
2026-06-154BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 15,294 @ $0 · Grant/award (A): 33,540 (derivative) @ $0EDGAR
2026-06-024BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 1,262 @ $8.91EDGAR
2026-03-164PRECIGEN, INC. (PGEN)Option exercise (M): 71,839 · Option exercise (M): 71,839 (derivative) @ $0EDGAR
2026-03-124PRECIGEN, INC. (PGEN)Grant/award (A): 14,245 @ $3.51 · Grant/award (A): 35,612 (derivative) @ $0 · Grant/award (A): 41,073 (derivative) @ $0EDGAR
2026-03-034BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 1,285 @ $8.75EDGAR
2025-12-024BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 1,566 @ $7.18EDGAR
2025-09-034BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 1,353 @ $8.31EDGAR
2025-06-164BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 12,500 @ $0 · Grant/award (A): 27,181 (derivative) @ $0EDGAR
2025-06-034BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 333 @ $10.75EDGAR
2025-05-064BIOCRYST PHARMACEUTICALS INC (BCRX)Grant/award (A): 1,866 @ $0 · Grant/award (A): 4,079 (derivative) @ $0EDGAR
2025-03-174PRECIGEN, INC. (PGEN)Grant/award (A): 28,735 @ $1.74 · Option exercise (M): 87,412 · Grant/award (A): 71,839 (derivative) @ $0 · Option exercise (M): 87,412 (derivative) @ $0 · Grant/award (A): 83,517 (derivative) @ $0EDGAR
2024-03-184PRECIGEN, INC. (PGEN)Grant/award (A): 34,965 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0EDGAR
2024-03-124PRECIGEN, INC. (PGEN)Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0EDGAR
2023-08-154PRECIGEN, INC. (PGEN)Purchase (P): 400,000 @ $1.72EDGAR
2023-03-134PRECIGEN, INC. (PGEN)Grant/award (A): 42,735 @ $1.17 · Grant/award (A): 106,837 (derivative) @ $0 · Grant/award (A): 125,489 (derivative) @ $0EDGAR
2023-02-244PRECIGEN, INC. (PGEN)Option exercise (M): 61,576 · Option exercise (M): 61,576 (derivative) @ $0EDGAR
2022-03-294PRECIGEN, INC. (PGEN)Option exercise (M): 16,212 · Option exercise (M): 16,212 (derivative) @ $0EDGAR
2022-02-244PRECIGEN, INC. (PGEN)Grant/award (A): 24,630 @ $2.03 · Grant/award (A): 61,576 (derivative) @ $0 · Grant/award (A): 83,189 (derivative) @ $0EDGAR
2021-03-294PRECIGEN, INC. (PGEN)Grant/award (A): 6,485 @ $7.71 · Grant/award (A): 16,212 (derivative) @ $0 · Grant/award (A): 22,107 (derivative) @ $0EDGAR
2021-03-164PRECIGEN, INC. (PGEN)Option exercise (M): 62,189 · Option exercise (M): 62,189 (derivative) @ $0EDGAR
2021-03-054PRECIGEN, INC. (PGEN)Option exercise (M): 2,968 @ $5.69 · Option exercise (M): 2,968 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-03-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1583886 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs